Darifenacin
- Product NDC
- 72162-2570
- 11-digit product format
- 721622570
- Labeler code
- 72162
- Product ID
- 72162-2570_2a6e97d9-19e4-42aa-86e8-27bab91f059d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Darifenacin
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA205209
- Marketing category
- ANDA
- Marketing start
- 2016-11-18
- Substance
- DARIFENACIN HYDROBROMIDE
- Active strength
- 7.5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| CR02EYQ8GV | DARIFENACIN HYDROBROMIDE | 133099-07-7 | DARIFENACIN HYDROBROMIDE |
| APG9819VLM | DARIFENACIN | 133099-04-4 | Darifenacin |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72162-2570-3 | 72162257003 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2570-3) | 2025-11-17 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Darifenacin | Bryant Ranch Prepack | 2025-11-17 | HUMAN PRESCRIPTION DRUG LABEL | 100 |